Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions
Sign Up to like & getrecommendations! Published in 2017 at "Pharmaceutical Medicine"
DOI: 10.1007/s40290-017-0200-z
Abstract: BackgroundIncreasingly, patients are expected to influence decisions previously reserved for regulatory agencies, pharmaceutical companies, and healthcare professionals. Individual patients have previously represented their patient population when rare, serious adverse events (AEs) were weighed as part… read more here.
Keywords: aes; risk; regulatory decisions; serious adverse ... See more keywords
Evaluating Chemical Mixtures in Epidemiological Studies to Inform Regulatory Decisions
Sign Up to like & getrecommendations! Published in 2023 at "Environmental Health Perspectives"
DOI: 10.1289/ehp11899
Abstract: Background: Epidemiological studies are increasingly going beyond the evaluation of health effects of individual chemicals to consider chemical mixtures. To our knowledge, the advantages and disadvantages of addressing chemical mixtures for informing regulatory decisions—as opposed… read more here.
Keywords: epidemiological studies; health; mixtures epidemiological; chemical ... See more keywords